An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology framework.

Saved in:
Bibliographic Details
Title: An international modified Delphi study to prioritise levels of evidence and outcomes to appraise radiotherapy innovation in the ESTRO Value-Based Radiation Oncology framework.
Authors: Vandemaele M; Department of Radiation Oncology, Ghent University Hospital, Ghent University, Ghent, Belgium. Electronic address: miet.vandemaele@ugent.be., Leech M; Applied Radiation Therapy Trinity, Discipline of Radiation Therapy, School of Medicine, Trinity College Dublin, Dublin, Ireland; Trinity St James's Cancer Institute, Trinity College Dublin, Dublin, Ireland., Aznar M; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK., Blanchard P; Department of Radiation Oncology, Oncostat U1018 INSERM, Université Paris-Saclay, Gustave-Roussy, Villejuif, France., Borr S JM; Department of Clinical Sciences, University of Barcelona and Bellvitge Biomedical Research Institute, Barcelona, Spain., Lievens Y; Radiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium., Aggarwal A; Institute of Cancer Policy, King's College London, London, UK; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Corporate Authors: ESTRO Value-Based Radiation Oncology collaborators
Source: The Lancet. Oncology [Lancet Oncol] 2026 Mar; Vol. 27 (3), pp. e160-e169.
Publication Type: Journal Article; Review
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(25)00732-6